Bermingham Nessan

CIK 00013777593 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001377759

Recent Transactions

26 trades

Award
Korro Bio, Inc.$KRRO
Stock Option (Right to Buy)
2025-06-11+6,010→ 6,010 total
Award
Korro Bio, Inc.$KRRO
Stock Option (Right to Buy)
2024-06-11+5,190→ 5,190 total
Award
Korro Bio, Inc.$KRRO
Stock Option (Right to Buy)
2023-11-03+24,712→ 24,712 total
Award
Korro Bio, Inc.$KRRO
Common Stock
2023-11-03+35,114→ 35,114 total
Award
Korro Bio, Inc.$KRRO
Stock Option (Right to Buy)
2023-11-03+67,061→ 67,061 total
Disposition to Issuer
F-star Therapeutics, Inc.
Stock Option (right to buy)
2023-03-08−20,000→ 0 total
Disposition to Issuer
F-star Therapeutics, Inc.
Stock Option (right to buy)
2023-03-08−20,000→ 0 total
Disposition to Issuer
F-star Therapeutics, Inc.
Common Stock
2023-03-08$7.12/sh−6,328→ 0 total
Disposition to Issuer
F-star Therapeutics, Inc.
Stock Option (right to buy)
2023-03-08−34,111→ 0 total
Disposition from Tender
F-star Therapeutics, Inc.
Common Stock
2023-03-08$7.12/sh−97,547→ 6,328 total
Award
F-star Therapeutics, Inc.
Stock Option
2022-06-17+20,000→ 20,000 total
Award
F-star Therapeutics, Inc.
Stock Option
2021-06-04+20,000→ 20,000 total
Award
F-star Therapeutics, Inc.
Common Stock
2021-02-01+87,000→ 103,875 total
Award
F-star Therapeutics, Inc.
Common Stock
2020-11-20+16,875→ 16,875 total
Award
F-star Therapeutics, Inc.
Stock Option (right to buy)
2020-11-20+34,111→ 34,111 total
Award
F-star Therapeutics, Inc.
Restricted Stock Units
2020-11-20+16,875→ 16,875 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2017-12-12+292,500→ 292,500 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2017-12-08$20.82/sh−94,143→ 458,250 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2017-12-07$21.05/sh−103,574→ 579,959 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2017-12-07$21.46/sh−27,566→ 552,393 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2017-12-06$20.28/sh−99,033→ 696,000 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2017-12-06$20.84/sh−12,467→ 683,533 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2017-06-01$11.95/sh+8,400→ 795,033 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2017-01-06+270,000→ 270,000 total
Conversion
Intellia Therapeutics, Inc.$NTLA
Founder Stock
2016-05-11−675,883→ 0 total
Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2016-05-11+437,019→ 786,633 total

Companies

Recent Filings

Address

C/O KORRO BIO, INC. 60 FIRST STREET, 2ND FLOOR, SUITE 250

CAMBRIDGE, MA, 02141

View on SEC.gov